Accuray To Report Financial Results For Fourth Quarter And Year End Fiscal 2014

SUNNYVALE, Calif., Aug. 7, 2014 (GLOBE NEWSWIRE) -- Accuray Incorporated (Nasdaq:ARAY) announced today that it will report results for its fourth quarter and fiscal year ended June 30, 2014 on Thursday, August 21, 2014 after the market closes.

A conference call to review the results will begin at 1:30 p.m. PT/4:30 p.m. ET and will be hosted by Joshua H. Levine, President and Chief Executive Officer and Gregory Lichtwardt, Executive Vice President, Operations and Chief Financial Officer.

The conference call dial-in numbers are 1-866-318-8617 (USA) or 1-617-399-5136 (International), Conference ID: 40871448. In addition, a dial-up replay of the conference call will be available beginning August 21, 2014 at 5:30 p.m. PT/8:30 p.m. ET and ending on August 28, 2014. The replay telephone number is 1-888-286-8010 (USA) or 1-617-801-6888 (International), Conference ID: 81390653.

A live webcast of the call will also be available from the Investor Relations section of the company's website at http://www.accuray.com/investors. A webcast replay can be accessed on the website beginning Thursday, August 21, 2014 at approximately 5:30 p.m. PT/8:30 p.m. ET. The replay will remain available until Accuray announces its results for the first quarter of fiscal 2015, ending September 30, 2014.

About Accuray

Accuray Incorporated (Nasdaq:ARAY), is a radiation oncology company that develops, manufactures and sells precise, innovative treatment solutions that set the standard of care with the aim of helping patients live longer, better lives. The Company's leading-edge technologies deliver the full range of radiation therapy and radiosurgery treatments. For more information, please visit www.accuray.com .
CONTACT: Jamar Ismail         Investor Relations, Westwicke Partners         +1 (415) 513-1282         jamar.ismail@westwicke.com                  Media: Beth Kaplan         Public Relations Director, Accuray         +1 (408) 789.4426         bkaplan@accuray.com

If you liked this article you might like

Accuray (ARAY) Stock Sharply Lower After Q4 Results, Guidance

Will Accuray (ARAY) Stock Fall on Q4 Miss, Downbeat Outlook?

Trade These 5 Biotech Breakouts Now for Big Gains

Accuray (ARAY) Strong On High Relative Volume Today

Accuray (ARAY) Highlighted As Weak On High Volume